These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7805128)

  • 1. Synthesis and structure-activity relationships of new (5R,8S,10R)-ergoline derivatives with antihypertensive or dopaminergic activity.
    Ohno S; Koumori M; Adachi Y; Mizukoshi K; Nagasaka M; Ichihara K
    Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2042-8. PubMed ID: 7805128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of new (5R,8R,10R)-ergoline derivatives with antihypertensive or dopaminergic activity.
    Ohno S; Adachi Y; Koumori M; Mizukoshi K; Nagasaka M; Ichihara K; Kato E
    Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1463-73. PubMed ID: 7923470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antihypertensive activity of 2,4-dioxoimidazolidin-1-yl and perhydro-2,4-dioxopyrimidin-1-yl ergoline derivatives.
    Mantegani S; Brambilla E; Caccia C; Chiodini L; Ruggieri D; Lamberti E; Di Salle E; Salvati P
    Farmaco; 1998 Apr; 53(4):293-304. PubMed ID: 9658588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ergot alkaloids. New ergolines as selective dopaminergic stimulants.
    Stütz PL; Stadler PA; Vigouret JM; Jaton A
    J Med Chem; 1978 Aug; 21(8):754-7. PubMed ID: 567695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive ergoline derivatives.
    Mantegani S; Temperilli A; Traquandi G; Salvati P; Di Salle E; Lamberti E; Bonsignori A
    Drug Des Deliv; 1987 May; 1(4):313-23. PubMed ID: 3509340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of BAM-1120, a novel ergoline derivative, on central dopaminergic functions in rats.
    Ichihara K; Kamei H; Okumura K; Mizukoshi K; Nagasaka M
    Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):561-6. PubMed ID: 9819799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity.
    McQuaid LA; Latz JE; Clemens JA; Fuller RW; Wong DT; Mason NR
    J Med Chem; 1989 Oct; 32(10):2388-96. PubMed ID: 2571732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the antihypertensive effect of FCE 22716, a new ergoline derivative, in the spontaneously hypertensive rat.
    Salvati P; Bondiolotti GP; Caccia C; Vaghi F; Bianchi G
    Pharmacology; 1989; 38(2):78-92. PubMed ID: 2727050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bi- and tricyclic ergoline analogs with dopaminergic actions].
    Gmeiner P
    Pharm Unserer Zeit; 1994 Jun; 23(3):169-73. PubMed ID: 7913751
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive rats.
    Hojo M; Tanaka Y; Katayama O; Teramoto N
    Arzneimittelforschung; 1993 Aug; 43(8):847-51. PubMed ID: 8216440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of peripheral dopamine receptors in the antihypertensive effect of a new ergoline derivative (355/1057).
    Salvati P; Bianchi G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):291-304. PubMed ID: 4026460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antihypertensive activity of some 1,3,4-thiadiazole derivatives.
    Vio L; Mamolo MG; Laneve A
    Farmaco; 1989 Feb; 44(2):165-72. PubMed ID: 2775413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine].
    Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M
    Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive ergolinepropionamides.
    Bernardi L; Bosisio G; Mantegani S; Sapini O; Temperilli A; Salvati P; di Salle E; Arcari G; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1094-8. PubMed ID: 6685485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amesergide and structurally related nor-D-ergolines: 5HT2 receptor interactions in the rat.
    Martinelli MJ; Bloomquist W; Peterson BC; Cohen ML
    J Med Chem; 1993 Sep; 36(18):2671-5. PubMed ID: 8410979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central effects of quinpirole on blood pressure of spontaneously hypertensive rats.
    van den Buuse M
    J Pharmacol Exp Ther; 1992 Jul; 262(1):303-11. PubMed ID: 1352551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive action and alpha-adrenolytic properties of a new dopaminergic agonist, CU 32-085, in the rat.
    Morales-Olivas FJ; Palop V; Rubio E; Esplugues J
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):71-8. PubMed ID: 6151381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparkinsonian effects of BAM-1110, a novel ergoline derivative, in MPTP-treated cynomolgus monkeys.
    Kuno S; Mizuta E; Sakamoto H; Ichihara K; Nagasaka M
    Clin Neuropharmacol; 1998; 21(1):35-40. PubMed ID: 9579283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.